Progress and challenges of confirmatory trials for cancer drugs granted conditional approval in China
Saved in:
| Main Authors: | Xingxian Luo, Yang Xu, Xin Du, Xufeng Lv, Si Chen, Yue Yang, Lin Huang, Xiaohong Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-11-01
|
| Series: | The Lancet Regional Health. Western Pacific |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666606524002323 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy and safety of targeted agents approved for advanced non-small cell lung cancer in China: a cross-sectional analysis
by: Xingxian Luo, et al.
Published: (2025-02-01) -
Limitation Period for Conditional Tax Exemptions Granted Under European Union Grants
by: Birol Ubay
Published: (2024-11-01) -
Drug treatment of breast cancer brain metastases: progress and challenges
by: Jialing Luo, et al.
Published: (2025-06-01) -
Specific Aspects and Significance of Subgroup Assessment in Confirmatory Clinical Trials
by: O. I. Basova, et al.
Published: (2021-07-01) -
Confirmatory Factor Analysis and Propensity to Cheat Scale Validation in the Ethiopian Public Higher Education Institutions [version 3; peer review: 1 approved, 2 approved with reservations, 1 not approved]
by: Tesfaye Semela, et al.
Published: (2025-07-01)